Home Portfolio Press About Contact

Great companies start with someone who believes.

Seven Hound Ventures partners with founders who are shaping what comes next — across AI, biotech, longevity, fintech, and frontier technology.

Track Record
40+
Investments
3
NASDAQ IPOs
4
Acquisitions
$2.4B+
Acquisition Value
Tilray
First cannabis IPO on NASDAQ
IPO · 2018
MindMed
Psychedelic medicine biotech
NASDAQ · 2020
ATAI Life Sciences
Psychedelic medicine biotech
NASDAQ · 2021
Beckley Psytech
Acquired by ATAI
2025
Gilgamesh
Acquired by AbbVie
~$1.2B · 2025
Transcend
Acquired by Otsuka
~$1.225B · 2026
The Block
Acquired by Foresight Ventures
2023
Our Approach

Conviction-first investing across what matters most.

We look for exceptional founders tackling large, meaningful problems — then back them early with capital and conviction. From AI and healthspan to fintech and frontier tech, we go where the most talented founders are building what comes next.